Home >> Research Area >>Natural Products>>Alkaloids>> 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol

2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol

CAS# 162359-55-9

2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol

Catalog No. BCN1542----Order now to get a substantial discount!

Product Name & Size Price Stock
2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol: 5mg $17 In Stock
2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol: 10mg Please Inquire In Stock
2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol: 20mg Please Inquire Please Inquire
2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol: 50mg Please Inquire Please Inquire
2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol: 100mg Please Inquire Please Inquire
2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol: 200mg Please Inquire Please Inquire
2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol: 500mg Please Inquire Please Inquire
2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol: 1000mg Please Inquire Please Inquire

Quality Control of 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol

Number of papers citing our products

Chemical structure

2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol

3D structure

Chemical Properties of 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol

Cas No. 162359-55-9 SDF Download SDF
PubChem ID 107970 Appearance Powder
Formula C19H33NO2 M.Wt 307.47
Type of Compound Alkaloids Storage Desiccate at -20°C
Synonyms FTY720 free base
Solubility DMSO : 66.67 mg/mL (216.83 mM; Need ultrasonic)
Methanol : 30 mg/mL (97.57 mM; Need ultrasonic)
Ethanol : 7.69 mg/mL (25.01 mM; Need ultrasonic)
Chemical Name 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol
SMILES CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N
Standard InChIKey KKGQTZUTZRNORY-UHFFFAOYSA-N
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol

Description1. 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol analogs to significantly decrease pulmonary vascular leakage and inflammation in vitro and in vivo. 2. 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol significantly reduces multiple indices of alveolar and vascular permeability in a lipopolysaccharide-mediated murine model of ALI.
TargetsImmunology & Inflammation related

2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 3.2523 mL 16.2617 mL 32.5235 mL 65.047 mL 81.3087 mL
5 mM 0.6505 mL 3.2523 mL 6.5047 mL 13.0094 mL 16.2617 mL
10 mM 0.3252 mL 1.6262 mL 3.2523 mL 6.5047 mL 8.1309 mL
50 mM 0.065 mL 0.3252 mL 0.6505 mL 1.3009 mL 1.6262 mL
100 mM 0.0325 mL 0.1626 mL 0.3252 mL 0.6505 mL 0.8131 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol

Fingolimod is a sphingosine 1-phosphate (S1P) antagonist with IC50 of 0.033 nM in K562 and NK cells.

In Vitro:The monocyte-derived immature dendritic cells (iDCs) are pretreated with various concentrations of S1P for various periods of time prior to their incubation with NK cells. Four hours incubation of autologous or allogeneic iDCs with 0.2-20 μM of S1P significantly protectes these cells from NK cell lysis. The IC50 values of S1P are calculated at 160 nM for autologous iDCs, and 34 nM for allogeneic iDCs. Next, the inhibitory effect of S1P is revered by various concentrations of Fingolimod or SEW2871, with an IC50 effect of 173 or 15 nM, respectively[1]. Fingolimod has been reported to reduce LPA synthesis via inhibition of the lysophospholipase autotaxin. Fingolimod treatment correlates with a significant elevation of axonal cAMP, a crucial factor for axonal outgrowth. Additionally, Fingolimod significantly reduces LPA levels in the injured nerve. PF-8380 treatment correlates with improved myelin thickness[2].

In Vivo:Fingolimod treatment results in significantly increased nerve conduction at 14 days post-crush in wildtype C57BL/6 mice. However, Foxn1-/- mice, which are devoid of T- but not B-lymphocytes, show an improvement of nerve regeneration under fingolimod treatment. Although the mean increase in nerve conduction velocity in both fingolimod-treated and controlFoxn1-/- mice implies a potentially positive role of T-lymphocyte deficiency on nerve regeneration, only fingolimod-treated Foxn1-/- mice show a significant improvement compared to C57BL/6 controls and performed better in the functional analysis[2]. Treatment of the animals with Fingolimod for 28 d results in a clear reduction in the binding of 18F-GE180 when compare with vehicle-treated animals and evaluated by ex vivo autoradiography. Quantification of the binding of the radiotracer revealed a significant reduction in the binding potential of 18F-GE180 (P<0.0001) after treatment with Fingolimod[3].

References:
[1]. Rolin J, et al. FTY720 and SEW2871 reverse the inhibitory effect of S1P on natural killer cell mediated lysis of K562 tumor cells and dendritic cells but not on cytokine release. Cancer Immunol Immunother. 2010, 59(4), 575-586. [2]. Szepanowski F, et al. Fingolimod promotes peripheral nerve regeneration via modulation of lysophospholipid signaling. J Neuroinflammation. 2016 Jun 10;13(1):143. [3]. Airas L, et al. In vivo PET imaging demonstrates diminished microglial activation after fingolimod treatment in an animal model of multiple sclerosis. J Nucl Med. 2015 Feb;56(2):305-10. [4]. Shirakabe K, et al. Modification of lymphocyte migration to Peyer's patches by inhibition of sphingosine-1-phosphate lyase ameliorates murine colitis. J Gastroenterol Hepatol. 2018 Jan 15.

Featured Products
New Products
 

References on 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol

Synthetic analogs of FTY720 [2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol] differentially regulate pulmonary vascular permeability in vivo and in vitro.[Pubmed:19592667]

J Pharmacol Exp Ther. 2009 Oct;331(1):54-64.

Novel therapies are needed to address the vascular endothelial cell (EC) barrier disruption that occurs in inflammatory diseases such as acute lung injury (ALI). We previously demonstrated the potent barrier-enhancing effects of both sphingosine 1-phosphate (S1P) and the structurally similar compound FTY720 [2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol] in inflammatory lung injury. In this study, we examined the therapeutic potential of several novel FTY720 analogs to reduce vascular leak. Similar to S1P and FTY720, the (R)- and (S)-enantiomers of FTY720 phosphonate and enephosphonate analogs produce sustained EC barrier enhancement in vitro, as seen by increases in transendothelial electrical resistance (TER). In contrast, the (R)- and (S)-enantiomers of FTY720-regioisomeric analogs disrupt EC barrier integrity in a dose-dependent manner. Barrier-enhancing FTY720 analogs demonstrate a wider protective concentration range in vitro (1-50 microM) and greater potency than either S1P or FTY720. In contrast to FTY720-induced EC barrier enhancement, S1P and the FTY720 analogs dramatically increase TER within minutes in association with cortical actin ring formation. Unlike S1P, these FTY720 analogs exhibit differential phosphorylation effects without altering the intracellular calcium level. Inhibitor studies indicate that barrier enhancement by these analogs involves signaling via G(i)-coupled receptors, tyrosine kinases, and lipid rafts. Consistent with these in vitro responses, the (S)-phosphonate analog of FTY720 significantly reduces multiple indices of alveolar and vascular permeability in a lipopolysaccharide-mediated murine model of ALI (without significant alterations in leukocyte counts). These results demonstrate the capacity for FTY720 analogs to significantly decrease pulmonary vascular leakage and inflammation in vitro and in vivo.

Description

Fingolimod is a sphingosine 1-phosphate (S1P) antagonist with IC50 of 0.033 nM in K562 and NK cells. Fingolimod also is a pak1 activator, a immunosuppressant.

Keywords:

2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol,162359-55-9,FTY720 free base,Natural Products, buy 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol , 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol supplier , purchase 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol , 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol cost , 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol manufacturer , order 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol , high purity 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: